Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02063308 · ClinicalTrials.gov registry record · NA
Oxaloacetate Pharmacokinetics and Safety
A NA study of Alzheimers Disease, sponsored by Russell Swerdlow, MD.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
- 1
- Study location
NCT02063308: Completed NA study of Alzheimers Disease, sponsored by Russell Swerdlow, MD.
NCT02063308 is a NA study of Alzheimers Disease that has completed, run by Russell Swerdlow, MD. The registered enrollment target is 6 participants, below the 4,061-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02063308, a NA study of Alzheimers Disease, has completed, sponsored by Russell Swerdlow, MD.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
By doing this study, researchers hope to learn how much oxaloacetate (OAA) ends up in the blood after OAA capsules are swallowed, and to assess whether persons with Alzheimer's disease who take OAA for one month have any side-effects.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Oxaloacetate (OAA)
Study Locations (1)
Kansas
- University of Kansas Medical Center - Kansas City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2014-02 |
| Est. Completion | 2014-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02063308
The ClinicalTrials.gov registry entry for NCT02063308 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,061-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (100% lower). The listed sponsor is Russell Swerdlow, MD, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alzheimers Disease appearing as the primary indexed condition, and to 1 intervention - of which Oxaloacetate (OAA) is the first listed.
NCT02063308 reports 1 study location spanning 1 distinct geographic area - top geographies include Kansas.
Frequently Asked Questions
What is clinical trial NCT02063308 about?
NCT02063308 is a clinical study titled "Oxaloacetate Pharmacokinetics and Safety". By doing this study, researchers hope to learn how much oxaloacetate (OAA) ends up in the blood after OAA capsules are swallowed, and to assess whether persons with Alzheimer's disease who take OAA for one month have any side-effects.
What is the current status of trial NCT02063308?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2014-02. Estimated completion is 2014-06.
What conditions does trial NCT02063308 study?
This clinical trial studies the following conditions: Alzheimers Disease.
What interventions are being tested in trial NCT02063308?
The interventions under investigation include: Oxaloacetate (OAA) (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT02063308?
This trial is sponsored by Russell Swerdlow, MD, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02063308 being conducted?
This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimers Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
University of Central Florida Music Study
RECRUITING · NA
-
Locomotion Adaptation Deficits in Older Adults With Mild Cognitive Impairment and Alzheimers Disease
RECRUITING · NA
-
Pulsed Electromagnetic Field Treatment With Dementia Patients
RECRUITING · NA
-
Transcranial Photobiomodulation (tPBM) in Alzheimer's Disease Study
RECRUITING · NA
-
Chronic Treatment of Alzheimer's Disease by Gamma Light and Sound Therapy
RECRUITING · NA
-
A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
RECRUITING · NA
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.